Delivery Order SPE2DB25D3012-SPE2DB26FWVTY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a ceiling value of $7,429.80. This is a firm fixed price delivery order with an ultimate completion date of June 25, 2025, awarded on June 3, 2025, and involves no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for pain management in osteoarthritis, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,714.90 on September 25, 2025, for the supply of Zilretta 32 mg vials, with performance completion targeted for October 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 2, 2025. This is a competitively awarded, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a $7,429.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $8,915.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract, executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside contract, awarded on September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Zilretta is a corticosteroid injection used for osteoarthritis pain management, and this order fulfills medical...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVTYDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $4,457.88 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. Zilretta is a specialized injectable medication used for pain management in orthopedic applications, reflecting the breadth of pharmaceutical commodities provided through this comprehensive federal medical supply relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/4/25 |